 |
Lantus
insulin: a possible link with cancer which requires further investigation |
| |
Transcript of the statement by Prof Smith and
Prof Gale along with downloads of the papers (EASD) |
| |
|
|
Statement
from the International Diabetes Federation - Possible Link Between
Insulin Glargine and Cancer |
| |
The International Diabetes Federation today
called for urgent assessment and responses from regulatory authorities
into a possible link between the use of insulin glargine (an insulin
analogue) and increased risk of cancer (IDF) |
| |
|
|
Diabetologists
try to block GP use of new diabetes drugs |
| |
Consultant diabetologists have launched an attempt
to prevent GPs prescribing the newest class of type 2 diabetes
drugs - subscription (Pulse, UK) |
| |
|
|
Diabetes
UK's Measure Up Roadshow is a success |
| |
Diabetes UK has so far encouraged more than
10,000 people in the UK to measure their waists and find out if
they are at risk of developing Type 2 diabetes with its national
Measure Up Roadshow (Diabetes UK) |
| |
|
|
New
tool finds best heart disease and stroke treatments for patients
with diabetes |
| |
Researchers from North Carolina State University
and Mayo Clinic have developed a computer model that medical doctors
can use to determine the best time to begin using statin therapy
in diabetes patients to help prevent heart disease and stroke (EurelAlert) |
| |
|
|
Generex
Sees Favorable Results From MetControl(tm) Chewing Gum Bio-equivalency
Study Leading to Glob |
| |
Management believes the results provide convincing
evidence that MetControl(tm) and Metformin tablets are therapeutically
equivalent and therefore interchangeable (Generex Biotechnology
Corporation) |
| |
|
|
Takeda
Submitted an Application for an Additional Indication of Alogliptin
for Combination Therapy with Thiazolidinediones |
| |
Also a new drug application of fixed-dose combination
of alogliptin and pioglitazone HCl (generic name, tradename in
Japan:Actos ®) to the Ministry of Health, Labour and Welfare in Japan (PharmaLive) |
| |
|
|
Inflammatory
mediators in morbidly obese subjects; associations with glucose
abnormalities and changes after oral glucose |
| |
Morbid obesity and glucose intolerance were
associated with lower adiponectin levels and higher CRP levels,
thus supporting a relationship between obesity, glucose homeostasis
and inflammation (European Journal of Endocrinology) |
| |
|
